About
Repurposed Peptide
Areas of Focus
Categories
Gene Therapy, RNA & Peptide TherapyAustralia
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
120
By Phase
PHASE1: 2PHASE2: 2
By Status
COMPLETED: 3TERMINATED: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Today
Hover over trial bars to see details
Recent Trials
NCT05298306Lead Sponsor
A Two-part Proof-of-Concept Study Assessing the Safety and Efficacy of LAT8881 in Lumbar Radicular Pain
PHASE1Completed
26 participants
Started: May 17, 2022 · Completed: Jun 16, 2023
NCT04153409Lead Sponsor
A Proof of Concept Study of the Efficacy and Safety of Oral LAT8881 in Acute Migraine
PHASE2Completed
21 participants
Started: Sep 24, 2019 · Completed: Apr 10, 2020
NCT03865953Lead Sponsor
Oral LAT8881 in Neuropathic Pain
PHASE2Completed
53 participants
Started: Apr 9, 2019 · Completed: May 3, 2020
NCT02063594Lead Sponsor
Single Dose Safety, Tolerability and Pharmacokinetic Study of NCTX in Healthy Volunteers
PHASE1Terminated
20 participants
Started: Mar 31, 2014 · Completed: Oct 31, 2014
Locations (1)
Headquarters
Melbourne, Australia
Map
Loading map...